Announcements
- Final Results
- Total Voting Rights
- Placing to Raise US$4.2 million
- FDA Consents to Phase I Trials of HEMO-CAR-T
- Approval and Issuance of U.S. Conditioning Patent
- Submission of Complete Response to Clinical Hold
- HEMO-CAR-T Process Qualification Run Completed
- Placing to Raise £534,375
- CBR Expanded to Treatment of Cancer
- Lentivirus Re-manufacturing Completed
More ▼
Key statistics
As of last trade Hemogenyx Pharmaceuticals PLC (HOPHF:PKC) traded at 0.04, 0.00% above its 52-week low of 0.04, set on Jan 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.04 |
Average volume | -- |
---|---|
Shares outstanding | 1.34bn |
Free float | 1.20bn |
P/E (TTM) | -- |
Market cap | 19.59m GBP |
EPS (TTM) | -0.0061 GBP |
Data delayed at least 15 minutes, as of Jan 26 2024.
More ▼